Nu Skin develops and sells premium beauty and wellness products across nearly 50 markets, operating almost entirely through a multi-level direct selling network of Brand Affiliates who promote products person-to-person and through social media. Beauty products (roughly 38% of revenue) include skincare devices and cosmetics, with top lines like ageLOC TruFace and ageLOC LumiSpa. Wellness products (roughly 46% of revenue) are primarily nutritional supplements, with top lines including ageLOC TRME and LifePak. Brand Affiliates earn retail markups and multi-level sales compensation tied to product sales across their networks, and selling expense runs roughly 40% of core revenue. A strategic priority is Nu Skin's connected device platform — including the newly launched Prysm iO, a carotenoid measurement device that assesses nutritional health and generates personalized supplement recommendations. Management views Prysm iO as the centerpiece of an intelligent wellness platform, where device placements drive recurring supplement subscriptions. Nu Skin also operates Rhyz, an investment arm housing manufacturing subsidiaries (about 14% of revenue) that supply roughly 21% of Nu Skin's own product needs, enabling some vertical integration. Core business gross margin ran roughly 77% in FY25, supported by SKU rationalization and portfolio mix improvements. Growth priorities include scaling Prysm iO placements, expanding into India using a simplified developing-market model proven in Latin America, and continuing operational efficiency initiatives under Project Accelerate.